Concepedia

Yanqing Kan

YK

Statistics

Publications

22

Citations

1.1K

H-Index

18

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Albany Molecular Research (United States)

Tel Aviv University

Rutgers, The State University of New Jersey

Yanqing Kan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and life sciences.

Publications per year

1996–2021

22

Publications

22

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun

Mario Delgado, Ernesto J. Muñoz‐Elías, Yanqing Kan et al. · Journal of Biological Chemistry · 1998 · 181 citations · Full text

, , +17

Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Woong‐Ki Kim, Yanqing Kan, Doina Ganea et al. · PubMed · 2000 · 126 citations

, , +17

Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-α Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway

Woong‐Ki Kim, Yanqing Kan, Doina Ganea et al. · Journal of Neuroscience · 2000 · 120 citations · Full text

, , +17

Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity

Xiao-Ming Guan, Howard Chen, Peter H. Dobbelaar et al. · Cell Metabolism · 2010 · 87 citations · Full text

, , +16

Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

Iyassu K. Sebhat, Christopher S. Franklin, Michael M.‐C. Lo et al. · ACS Medicinal Chemistry Letters · 2010 · 66 citations · Full text

, , +17

1–5 of 22